Stock Analiz

Merck & Co., Inc. (MRK) earnings: date, estimates and history

Price $147.76 · data as of November 13, 2026

Next earnings report

Next reportNot announced yet
Quarterending December 31, 2026
EPS estimate$1.76
Revenue estimate$16.3B
Expected EPS growth−13.8%

The date appears here once Merck & Co. confirms it, usually two to four weeks before the report.

Track record

Beat EPS estimates5 of 5
Average surprise+18.7%
Average move on report day±2.1%

Merck & Co. beat the consensus earnings estimate in 5 of its last 5 reports, by +18.7% on average. On report days the stock moved 2.1% on average, up or down.

Earnings history

ReportedEPS estimateEPS actualSurpriseRevenueRevenue growthStock move
October 29, 2026
Sep/2026
$2.08$2.49+19.6%$18.1B—+3.8%
August 4, 2026
Jun/2026
$-0.26$-0.13+49.4%$16.6B+5.1%+0.4%
April 30, 2026
Mar/2026
$-1.47$-1.28+13.2%$16.3B+4.9%+1.1%
February 3, 2026
Dec/2025
$2.01$2.04+1.5%$16.4B+5.0%+4.4%
October 30, 2025
Sep/2025
$2.35$2.58+9.8%$17.3B+3.7%−0.7%

EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.

Frequently asked questions

When is Merck & Co.’s next earnings date?

Merck & Co. has not confirmed its next report date yet. Its last report was on October 29, 2026.

Did Merck & Co. beat earnings last quarter?

Yes, it reported EPS of $2.49 on October 29, 2026 against an estimate of $2.08 (a +19.6% surprise), and the stock moved +3.8% the next trading day.

What EPS do analysts expect next quarter?

The consensus estimate is $1.76 per share on revenue of about $16.3B.

Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar